MiMedx Group
MDXG
20 hedge funds and large institutions have $22.4M invested in MiMedx Group in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
258% more capital invested
Capital invested by funds: $6.26M → $22.4M (+$16.2M)
18% more funds holding
Funds holding: 17 → 20 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$14.5M |
| 2 |
RCM
Requisite Capital Management
Dallas,
Texas
|
+$172K |
| 3 |
NCM
Next Capital Management
New York
|
+$92K |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$4.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$41K |
| 2 |
TIM
Thompson Investment Management
Madison,
Wisconsin
|
-$14.1K |
MDXG Hedge Fund Activity: Q3 2019 in Review
20 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q3 2019, worth a combined $22.4M — up 258% from $6.26M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MDXG positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $14.5M. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $41K sold.
- 20 institutional investors held MiMedx Group (MDXG) as of Q3 2019, up from 17 in Q2 2019.
- Funds reported $22.4M of MiMedx Group stock for Q3 2019, up 258% quarter-over-quarter.
- 5 funds opened new MiMedx Group positions in Q3 2019 and 1 closed out, a net change of +4 holders.
- The largest MiMedx Group buyer in Q3 2019 was RTW Investments, an estimated $14.5M added.
- The largest MiMedx Group seller in Q3 2019 was Cambridge Investment Research Advisors, an estimated $41K sold.
Based on aggregated 13F filings for Q3 2019.